Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Plc Regulatory News (EML)

Share Price Information for Emmerson Plc (EML)

Share Price is delayed by 15 minutes
Get Live Data
2.00    -0.10 (-4.76%)
Bid:
1.80
Ask:
2.20
Spread: 0.40 (22.222%)
Market Cap: £26.73m
EML Live PriceLast checked at - London Stock Exchange

Intraday Emmerson Plc Share Chart

Research Note published by Shard Capital Partners

27 Mar 2019 11:40

RNS Number : 1950U
Emmerson PLC
27 March 2019
 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

 

27 March 2019

Emmerson Plc ("Emmerson" or the "Company")

Research Note published by Shard Capital Partners Establishes a Five-Year Price Target of c100p.

 

"EML's recent scoping study at Khemisset demonstrated a robust project with outstanding economics - sector leading capital intensity and bottom quartile AISC to Brazil. The combination of favourable location, excellent infrastructure and shallow mineralisation pushes Khemisset to the front of the queue in terms of upcoming projects om the potash space. EML's management has considerable potash experience and the track record to push Khemisset through feasibility and financing at a time of record MOP demand.", writes Phil Swinfen, Analyst at Shard Capital Partners, in a recently released equity research note on the Company ("the Note").

 

The Note establishes an initial price target of 12pence per share with the potential for the valuation to increase to c100p per share in the next five years: "Our SotP suggests a current intrinsic fair value of c.12p/sh based on conservative modelling inputs and a punitive 0.25%x NAV multiple reflecting the current stage of development…We see significant potential for value accretion as the company meets development milestones and de-risks, we see of SotP valuation rising from 12p on a risk adjusted basis today to c.100p at production (+5 years) on a pre financing basis."

 

Mr Swinfen identifies the strategic value of the Khemisset Potash Project which has "High margins and sector-leading capital intensity. We [Shard Capital Partners] calculate Khemisset's capital intensity is…half the industry average due to shallow mineralisation and minimal infrastructure build. Khemisset's total delivered cost to Brazil is bottom quartile with a considerable freight advantage over peer projects, virtually unrivalled in the sector." Subsequently, Shard Capital Partners can "see rationale for Khemisset to be of significant interest to major players in the potash/fertiliser space. Potential synergies exist with Moroccan-based OCP Group which is pursuing an aggressive strategy to double mining and triple processing capacity by 2027."

 

To download the full note please visit the following link: https://www.emmersonplc.com/investors/corporate-documents/

 

**ENDS**

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact: 

Hayden Locke

Emmerson Plc

Tel: +44 (0) 207 236 1177

Edward McDermott

 

 

 

James Biddle

Roland Cornish

Beaumont Cornish Limited

Financial Adviser

 

Tel: +44 (0) 207 628 3396

 

Jeremy King

 

Optiva Securities Limited

Broker

Tel: +44 (0) 3137 1904

 

 

 

Gaby Jenner

Melissa Hancock

St Brides Partners Ltd

Financial PR/IR

Tel: +44 (0) 20 7236 1177

 

 

 

 

 

Notes to Editors

Emmerson's primary focus is on developing the Khemisset Potash Project located in Northern Morocco. The project has a large JORC Resource Estimate (2012) of 311.4Mt @ 10.2% K2O and significant exploration potential with an accelerated development pathway targeting a low capex, high margin mine. Khemisset is perfectly located to capitalise on the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. This unique positioning means the project will receive a premium netback price compared to existing potash producers. The need to feed the world's rapidly increasing population is driving demand for potash and Emmerson is well placed to benefit from the opportunities this presents.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUBOARKWAOUAR
Date   Source Headline
30th Mar 20267:00 amRNSArbitration Memorial Submission
24th Mar 20267:00 amRNSResult of WRAP Retail Offer
20th Mar 20267:31 amRNSWRAP Retail Offer for up to £100,000
20th Mar 20267:30 amRNSResult of Placing and Subscription
20th Mar 20267:00 amRNSProposed Placing and Subscription
22nd Jan 20267:00 amRNSArbitration Update
26th Nov 20257:00 amRNSAppointment of Joint Broker
30th Sep 20257:00 amRNSInterim Results
24th Jul 202512:31 pmRNSResult of Annual General Meeting
1st Jul 20257:00 amRNSNotice of AGM
30th Jun 20253:36 pmRNS2024 Financial Results
1st May 20258:10 amRNSRequest for Arbitration
17th Mar 20257:00 amRNSLitigation Funding Update
13th Jan 20253:03 pmRNSAdditional Issuance of Shares and Rights
2nd Jan 20257:00 amRNSLitigation Funding Secured
12th Dec 20247:00 amRNSAdditional Issuance of Shares and Rights
6th Dec 20247:01 amRNSFundraising of £0.85 million
1st Nov 20247:00 amRNSNotice of dispute with Moroccan Government
28th Oct 20247:00 amRNSESIA Process, Board Changes, and Cash Management
14th Oct 20247:00 amRNSESIA Update
27th Sep 20247:00 amRNSInterim Results and Q3 Update
5th Jul 20247:00 amRNSQ2 Update
1st Jul 20247:00 amRNSChange of Nominated Advisor and Joint Broker
26th Jun 202411:33 amRNSResult of Annual General Meeting
31st May 202410:56 amRNSGrant of Share Options and PDMR dealing
31st May 20247:00 amRNSNotice of AGM and Posting of Annual Report
24th May 20247:00 amRNS2023 Financial Results
22nd Apr 202411:47 amRNSTR-1: Notification of major holdings
8th Apr 20244:45 pmRNSResults of Oversubscribed REX Retail Offer
8th Apr 20247:01 amRNSREX Retail Offer
8th Apr 20247:00 amRNSQ1 Update, Equity Placing and Retail Offer
11th Mar 20247:00 amRNSCommittee Upholds Environmental Approval Referral
1st Feb 20247:00 amRNSScoping Study on Breakthrough New Processing Route
8th Jan 20247:00 amRNSQ4 Update
21st Dec 20237:00 amRNSExtension of Mandated Lead Arrangers
26th Sep 20237:00 amRNSInterim Results for the six months to 30 June 2023
21st Sep 20237:00 amRNSQ3 2023 and Financing update
11th Sep 202311:38 amRNSMorocco Statement
11th Jul 202311:57 amRNSDirector/PDMR Shareholding
10th Jul 20234:30 pmRNSDirector/PDMR Shareholding
6th Jul 20232:49 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSQ2 Update
6th Jun 20237:00 amRNSExercise & Allotment of Shares
31st May 202312:01 pmRNSResult of AGM
5th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20237:00 amRNS2022 Financial Results and Q1 Update
14th Feb 20237:00 amRNSMandated Lead Arrangers Appointed for Financing
9th Jan 20237:00 amRNSQ4 Update
3rd Jan 20237:00 amRNSAppointment of Liberum as Nominated Advisor
21st Nov 20227:00 amRNSPotash and Salt Offtake MOUs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.